Veru Inc.
Organization details
- Legal name
- Veru Inc.
- Former names
- Female Health Co
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Wisconsin
- Headquarters city
- Miami
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- VERU
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000863894
- EIN
- 39-1144397
Board of directors
-
Grace Hyun · DirectorSince 2023
-
Harry Fisch · Director · Chief Corporate OfficerSince 2023
-
Loren Mark Katzovitz · DirectorSince 2024
-
Lucy Lu · DirectorSince 2023
-
Mario Eisenberger · DirectorSince 2023
-
Michael L. Rankowitz · DirectorSince 2023
-
Mitchell Shuster Steiner · Director · President and CEOSince 2023
Chief executives
Director election results
Annual meeting of March 12, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.3%
-
93.2%
-
93.2%
-
94.1%
-
94.9%
-
95.2%
Board connections
1 of this board's directors also sit on 1 other board. 1 is in the same sector.
-
Fortress Biotech Inc. Same sectorvia Lucy Lu
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,842
- 1 purchase by 1 insider
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 13, 2026 | BARNETTE K GARY Officer (Chief Scientific Officer) | Open-market purchase | +1,800 | $2.69 | $4,842 |
| Feb 19, 2025 | Michael L. Rankowitz Director | Open-market purchase | +54,721 | $0.58 | $31,738 |
| Feb 18, 2025 | Michael L. Rankowitz Director | Open-market purchase | +95,279 | $0.55 | $52,403 |
| May 24, 2024 | Harry Fisch Director, Officer (Chief Corporate Officer) | Open-market purchase | +4,000 | $1.25 | $5,000 |
| May 24, 2024 | BARNETTE K GARY Officer (Chief Scientific Officer) | Open-market purchase | +5,000 | $1.34 | $6,700 |
| May 24, 2024 | Mitchell Shuster Steiner Director, Officer (President and CEO) | Open-market sale | −63,379 | $1.23 | $77,956 |
| May 23, 2024 | Mitchell Shuster Steiner Director, Officer (President and CEO) | Open-market sale | −300 | $1.35 | $405 |
| May 22, 2024 | Mitchell Shuster Steiner Director, Officer (President and CEO) | Open-market sale | −6,504 | $1.39 | $9,041 |
| May 17, 2024 | Mitchell Shuster Steiner Director, Officer (President and CEO) | Open-market sale | −28,066 | $1.32 | $37,047 |
| May 16, 2024 | Mitchell Shuster Steiner Director, Officer (President and CEO) | Open-market sale | −59,788 | $1.41 | $84,301 |
| May 15, 2024 | Harry Fisch Director, Officer (Chief Corporate Officer) | Open-market purchase | +6,711 | $1.49 | $9,999 |
| May 15, 2024 | Mitchell Shuster Steiner Director, Officer (President and CEO) | Open-market sale | −84,021 | $1.50 | $126,032 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Veru Inc.
Who is the CEO of Veru Inc.?
Mitchell Shuster Steiner is Veru Inc.'s President and CEO.
How many directors are on Veru Inc.'s board?
Veru Inc.'s board has 7 directors: Grace Hyun, Harry Fisch, Loren Mark Katzovitz, Lucy Lu, Mario Eisenberger, Michael L. Rankowitz and Mitchell Shuster Steiner.
Are Veru Inc. insiders buying or selling shares?
Over the last 12 months, Veru Inc. insiders bought $4,842 of shares in 1 purchase and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="veru-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.